Over the past few decades, vitamin D was proposed to be highly influential on female fertility and reproductive health. Its role was extensively studied and evaluated specifically in females with polycystic ovarian syndrome. Objectives: the aim of this research was to study the correlation between vitamin D and fertility in general, and in polycystic ovarian syndrome-associated infertility in particular. Methods: we searched Cochrane Library and PubMed for articles addressing the impact and role of vitamin D in fertility issues in females with polycystic ovary disease. Specifically-related topics were carefully reviewed and analyzed to summarize their conclusive results. Results and Discussion: Vitamin D was lower in females with PCOS and vitamin D administration had increased its level, improved metabolic disturbance and shortened inter-menstrual intervals in those patients. Patients with high vitamin D levels had a better success rate of invitro fertilization. However, it did not affect the time to pregnancy in PCOS women. Conclusion: Vitamin D is beneficial for improving metabolic as well as reproductive functions in women with PCOS. It is also essential for successful in-vitro fertilization, and it is probably protective against endometriosis. However, results from different studies are contradictory, and still there is no solid evidence that there is a cause-effect relationship between vitamin D and fertility.
INTRODUCTION
Vitamin D is one of the fat-soluble vitamins that can be exogenously taken, via certain types of food, or endogenously formed, through skin exposure to ultraviolet sun rays. The main wellestablished role of vitamin D is related to calcium metabolism, mineralization, and bone health. However, it was found that it is also implicated in the pathogenesis and risk amplification in certain medical diseases. Vitamin D deficiency or disturbed metabolism is encountered in many disorders such as cancer, autoimmune, infectious, endocrinal, as well as cardiovascular diseases (1) . Polycystic ovarian syndrome, on the other side, is one of the most common endocrinopathies, it affects 6-10% of females in the reproductive age worldwide. Patients with polycystic ovarian syndrome (PCO) present with menstrual irregularities and signs of hyperandrogenism (1) . Infertility, diabetes, obesity, and metabolic syndrome are not uncommon among those patients (2) . The pathophysiology of PCOS is complex; excessive pituitary gland secretion of luteinizing hormone (LH) that subsequently stimulate ovarian thecal cells for overproduction of androgens is one of the common proposed mechanisms (3) . PCOS is closely correlated with obesity, insulin resistance, and hyperinsulinemia which may augment the gonadotropin hormonal effect on ovaries (4) .
Study rationale and objectives:
Many researches had proposed a role of vitamin D in polycystic ovarian syndrome management, and eventually various studies had intensively focused on this point of research. The aim of this research article was to review the literature studies addressing the correlation between vitamin D and fertility in general, and Vitamin D in PCOS-associated fertility in particular.
METHODS
To achieve the review article objective, we conducted a systematic search of medical database, 2628 namely PubMed and Cochrane Library for articles addressing the correlation between fertility, polycystic ovary and vitamin D. The search results were closely inspected to select those with appropriately-related significant data. We selected studies and review articles specifying the role of vitamin D in females with polycystic ovary syndrome, the relationship between vitamin D and fertility, the association of vitamin D with polycystic ovary, and the impact of vitamin D administration on fertility for females with polycystic ovary syndrome. Data from selected results were analyzed carefully, organized, and summarized to reach conclusive remarks.
The study was approved by the Ethics Board of Taif University.
RESULTS
Literature studies showed contradictory results about the association of vitamin D and polycystic ovarian syndrome (PCOS) and/or fertility. Fang et al. (5) in their meta-analysis of 9 studies including 502 women with polycystic ovarian syndrome (PCOS) stated that there was a significant enhancing effect of vitamin D supplementation on reproductive functions through improving follicular development and increasing numbers of dominant follicles (OR 2.34). Vitamin D admiration had also increased the regulation of menstrual cycles in females with PCOS on metformin in comparison to giving metformin alone (OR 1.85). Additionally, Nick et al.
(1) in their review article in May 2015 indicated that vitamin D was significantly associated with fertility; it prevented endometriosis and ameliorated the reproductive dysfunction in patients with polycystic ovarian syndrome. On the contrary, Ming-Wei et al. (6) reported that in spite of the presence of many studies suggesting the association between vitamin D receptor (VDR) gene (one of the genes involved in vitamin D metabolism) and polycystic ovarian syndrome, no consistent conclusion could be made that vitamin D has a significant role in neither the pathophysiology nor the outcome of polycystic ovarian syndrome (6) . 
Irani et al.
(9) conducted a prospective randomized placebo-controlled trial on 68 women with PCOS to determine the effect of Vitamin D supplementation versus placebo on the disease outcome. Results from their study showed that vitamin D supplementation had significantly normalized vitamin D levels from 16.3±0.9 to 43.2±2.4ng/mL (p<0.01). It had also decreased the interval between menstrual cycles from 80±9 to 60±6 (p=0.4) and triglyceride level from 138±22 to 117±22 mg/dl (p=0.3).
Kim et al.
(10) in their case-control study on Korean women with polycystic ovarian syndrome found that there was no statistically significant difference between 25-hydroxy vitamin D levels among PCOS patients (19.6±6.6 ng/mL) and controls (20.1±7.4 ng/mL) with a p value of 0.696. Similarly, there was no significant difference in the overall prevalence of vitamin D deficiency among patients (57.9%) and controls (56.5%) (p=0.88).In disagreement with this study, Rainer et al. (12) reported a high prevalence of vitamin D deficiency among patients with PCOS, however, there was no significant association between vitamin D deficiency and the number of cycles to pregnancy [HR¼1.4 (95%CI 0.3-8.5)]. Dipanshu et al. (8) also reported a high prevalence of vitamin D deficiency among females with PCOS with a figure ranging from 67-85%. The average serum concentration of 25-hydroxy Vitamin d was <20ng/ml. Lower levels of vitamin D were associated with insulin resistance, low pregnancy rates, and menstrual irregularities, and signs of hyperandrogenism. Similarly, results from cross-sectional study conducted by Elida et al. (7) indicated that PCOS patients had significantly lower vitamin D levels when compared to controls, and obese PCOS ladies had even much lower level of vitamin D specifically those with waist-hip ratio of >0.85.
Studying the effect of vitamin D supplementation on fertility in general, Lerchbaum et al. (11) noticed that females with vitamin D levels of >30ng/mL had a higher success rate of their invitro fertilization (IVF) than their counterparts. This was attributed to the vitamin D effects on uterine endometrium. Vitamin D supplementation was also reported to be beneficial for women with PCOS in diminishing different metabolic diameters such as lipid profile; and it decreased incidence of endometriosis in animal models.
DICUSSION
Although the main well-known role of vitamin D is the regulation of mineralization, calcium metabolism, and bone health, another key function of the vitamin is regulation of cell growth. And because it is a fat-soluble seco-steroid chemical, it is vital for production of sex hormones inside the body. Additionally, it plays a considerable role in reproductive functions mainly through altering the signaling of anti-müllerian hormone, the sensitivity of follicle-stimulating hormone, and production of progesterone in human granulosa cells which subsequently affect ovarian follicle luteinization (13) . This is proposed due to the presence of Vitamin D receptors (VDR) in the placenta, ovary and uterine endometrium. . Over the past few decades, the correlation between vitamin D and fertility in general -or PCOS in particular -had become a matter of interest. The effect and role of vitamin D in improving infertility has been intensively researched. Although results from different studies were contradictory, there is a promising finding that propose a beneficial effect of vitamin D on improving fertility problems. For instance, reports of Lerchbaum et al. (11) Indicated that females with vitamin D levels of >30ng/mL had a higher success rate of their in-vitro fertilization (IVF) emphasize the vital role of vitamin D for maintain the integrity and health of the uterine endometrium. Findings by other researchers had stated that patients with vitamin D deficiency did not respond well to Clomid ovarian stimulation or to in-vitro fertilization (IVF) (15) . As regards the association of vitamin D and polycystic ovarian syndrome, many researchers had observed a significantly lower vitamin D level among PCOS women (8, 9, 11, 12) , it was even lower in obese PCOS (7) . Data indicated that vitamin D supplementation for those patient had improved their follicular development and increased the number of dominant follicles (5) . It has also decreased the interval between menstrual cycles in one study (9) . However, it did not seem to decrease the time or number of cycles to pregnancy (12) .Results from Irani et al.
(9) study provided a new possible role of vitamin D supplementation on the pathophysiology of PCOS by acting on TGF-β. Other studies (7, 8) assumed a probable role of vitamin D in insulin resistance. It seemed that vitamin D deficiency might aggravate insulin resistance and its correction might help control of the condition.
The findings reported by Kim et al. (10) Indicated that there was no statistically significant difference in neither the vitamin D level nor the prevalence of vitamin D deficiency between patients and controls signifying that the role of vitamin D in the pathogenesis of PCOS remains elusive.
In conclusion, there may be an evidence that Vitamin D supplementation to females with polycystic ovarian syndrome (PCOS) may improve their menstrual irregularities, insulin resistance, as well as pregnancy success rates. However, the contradictory results stated through different studies make this evidence limited and/or inadequate. The reviewed studies indicated that vitamin D administration induced significantly improved polycystic ovarian syndrome-associated fertility problems.
Vitamin D was also reported to enhance fertility on other aspects rather than PCOS, it was noted that it improves the success of in-vitro fertilization (12) , and protect against endometriosis (16) (17) (18) (19) (20) .While vitamin D impact on fertility and reproductive health is promising, data available are still inadequate and are not sufficient to establish a solid causal-effect relationship between fertility problems and vitamin D administration or deficiency. Further longitudinal multi-centric studies are still recommended to establish this hypothesis and to generate a consensus for usage of vitamin D in infertile patients.
CONCLUSION
Vitamin D is beneficial for improving metabolic as well as reproductive functions in women with PCOS. It is also essential for successful in-vitro fertilization, and it is probably protective against endometriosis. However, results from different studies are contradictory, and still
